Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
Triple Renal Pathology in a Patient With Myeloperoxidase-Associated Vasculitis, Diabetic Nephropathy, and Immunoglobulin A Nephropathy: A Case Report. (PubMed, Cureus) - Oct 15, 2026 - "Due to the cumulative toxicity profile of cyclophosphamide, she was transitioned to maintenance rituximab. This case highlights the critical importance of renal biopsy in diabetic patients presenting with atypical renal function decline or active urinary sediment. Furthermore, it demonstrates that a multimodal therapeutic approach is associated with substantial renal recovery in complex overlapping glomerular diseases." 
Journal • Acute Kidney Injury • ANCA Vasculitis • Diabetes • Diabetic Nephropathy • Focal Segmental Glomerulosclerosis • Glomerulonephritis • IgA Nephropathy • Lupus Nephritis • Metabolic Disorders • Nephrology • Renal Disease • Type 2 Diabetes Mellitus • Vasculitis • MPO
http://www.ncbi.nlm.nih.gov/pubmed/42872201
 
Akilandanayaki Angamuthu; Riddhi Patel; Supritha Sakhamuri; Yash Patel
 
Oct 15, 2026
 
Prev Next